Ulvestad Elling, Swensen Elisabeth, Simonsen Gunnar Skov, Schei Edvin
Mikrobiologisk avdeling, Haukeland universitetssykehus og Gades Institutt, Universitetet i Bergen, 5021 Bergen, Norway.
Tidsskr Nor Laegeforen. 2010 Jan 28;130(2):169-71. doi: 10.4045/tidsskr.10.0023.
During the second half of 2009 the Norwegian people experienced the first pandemic influenza since the Hong-Kong disease in 1968. The pandemic was initially believed to be severe, but it soon became evident that the disease was milder than anticipated. In spite of this the health authorities increased the level of threat and recommended general vaccination and exempt of oseltamivir (Tamiflu) from prescription requirements. In the paper we critically evaluate the evidence-base and consequences of these recommendations.
2009年下半年,挪威民众经历了自1968年香港流感以来的首次甲型H1N1流感大流行。起初人们认为这次大流行很严重,但很快就发现这种疾病比预期的要温和。尽管如此,卫生当局还是提高了威胁级别,并建议进行普遍接种疫苗,同时取消了对奥司他韦(达菲)的处方要求。在本文中,我们严格评估了这些建议的证据基础和后果。